Joanne Bryce

Chief Financial Officer

Joanne Bryce, CPA, brings over 15 years of strategic finance leadership across high-growth life sciences companies. She has a proven track record leading transformative transactions including public offerings, a $1B acquisition, and over $500M in capital raises, with deep expertise in fundraising, public company readiness, and scaling finance and operations.

Most recently, Ms. Bryce served as Interim Chief Financial Officer at SiteOne Therapeutics, where she participated in deal negotiations for the company’s $1B acquisition by Eli Lilly and managed all finance and human resources operations. Previously, as Chief Financial Officer and Treasurer at Disc Medicine (NASDAQ: IRON), she led the company’s reverse merger with Gemini Therapeutics, raised over $500M through multiple financing vehicles, and grew market cap from $350M to over $1B in the first year as a public company. Earlier, she provided part-time CFO services to multiple life sciences and technology companies and served as Chief Financial Officer at WiTricity Corporation, where she managed growth from pre-revenue to over $10M in annual revenue while raising over $35M in venture and strategic funding.

Ms. Bryce holds a BS in accounting from Babson College, where she graduated as Valedictorian, and is a CPA.